1.Application of Insect and Vine Medicinal Pairs in the Treatment of Postoperative Recurrence and Metastasis of Bladder Cancer:from the Perspective of Blood Collaterals Theory
Canlin WANG ; Sijia LIU ; Xin CHEN ; Jianxin LU ; Yaqiang ZHANG ; Shuqi SONG
Journal of Traditional Chinese Medicine 2026;67(10):1120-1124
Based on the theory of blood collateral, postoperative recurrence and metastasis of bladder cancer are considered to arise primarily from the binding of stasis and toxin, which accumulate and hide within the blood collaterals. Accordingly, treatment should focus on clearing and resolving the deeply concealed stasis toxin retained in the blood collaterals. The paired use of insect and vine medicinals may exert synergistic effects by simultaneously searching out and eliminating pathogenic factors, guiding the action of herbs to the channels, and unblocking the collaterals. Drawing on clinical practice, the stasis-toxin pathogenesis of postoperative recurrence and metastasis of bladder cancer can be divided into four stages including stagnation and astringent of collateral qi, formation of fixed stasis nests, transformation of persistent stasis into toxin, and deficiency of healthy qi with lingering toxin. Accordingly, four herb pairs are proposed for each stage based on conventional treatment, which are Dilong (Pheretima)-Daxueteng (Caulis Sargentodoxae), Shuizhi (Hirudo)-Jixueteng (Caulis Spatholobi), Wugong (Scolopendra)-Luoshiteng (Caulis Trachelospermi), and Quanxie (Scorpio)-Qianjinteng (stephania). Their potential modern pharmacological mechanisms are further discussed.
2.Buzhong Yiqitang Combined with Cisplatin Inhibits Lung Adenocarcinoma Cell Proliferation by Suppressing PDK1/Akt Signaling Pathway and Regulating Glycolysis
He LI ; Sijia BAI ; Wenjun LIU ; Jianguang WANG ; Jialu LYU ; Chun WANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(19):1-12
ObjectiveTo investigate the impact of Buzhong Yiqitang combined with cisplatin on the proliferation of human lung adenocarcinoma (A549) cells through regulation of the pyruvate dehydrogenase kinase 1 (PDK1)/protein kinase B (Akt) signaling pathway and influence on glycolysis. MethodsTranscriptome sequencing (RNA-seq) was employed to compare the expression of glycolysis-related genes between A549 cells and cisplatin-resistant human lung adenocarcinoma cells (A549/DDP). Small interfering RNA (siRNA) was employed to knock down PDK1, and the knockdown efficiency was verified by Western blot and Read-time PCR. The cell counting kit-8 (CCK-8) assay was used to assess the survival and viability of A549 cells under the following conditions: siRNA negative control+cisplatin (128, 64, 32, 16, 8, 4, 0 μmol·L-1), siPDK1+cisplatin (128, 64, 32, 16, 8, 4, 0 μmol·L-1), and siPDK1+cisplatin (128, 64, 32, 16, 8, 4, 0 μmol·L-1)+Buzhong Yiqitang (10%)-containing serum. The 20% inhibitory concentration (IC20) of the siRNA negative control+cisplatin group (7.832 μmol·L-1) was calculated and used as the subsequent cisplatin concentration. Colony formation assay was performed to evaluate the proliferation of A549 cells. Lactate and adenosine triphosphate (ATP) assay kits were used to measure lactate and ATP production. The mitochondrial membrane potential was detected with the fluorescent probe JC-1. Western blotting was conducted to examine the expression levels of PDK1, phosphorylated (p)-Akt, Akt, pyruvate kinase M2 (PKM2), glucose transporter 1 (GLUT1), pyruvate dehydrogenase (PDH), and lactate dehydrogenase A (LDHA). Confocal immunofluorescence was employed to detect PDK1 and p-Akt. ResultsRNA-seq results identified PDK1 as a highly expressed differential gene in glycolysis metabolism between A549 cells and A549/DDP cells, and it was highly expressed in tumor cells. Gene Set Enrichment Analysis (GSEA) revealed upregulated and downregulated genes in glycolysis and gluconeogenesis pathways. Western blot and RT-qPCR confirmed that PDK1-si-2 had the highest transfection efficiency, with a PDK1 knockdown rate exceeding 60%. CCK-8 assay determined the half-maximal inhibitory concentration (IC50) values for each group as (30.698±5.348), (16.372±3.562), (13.237±1.573) μmol·L-1, while the IC20 of cisplatin in siRNA negative control-transfected A549 cells was (7.832±0.672) μmol·L-1. Compared with the siRNA negative control group, the siRNA negative control+cisplatin group showed decreased colony formation rate, reduced lactate production, lowered mitochondrial membrane potential, downregulated protein levels of p-Akt, GLUT1, PDK1, PDH, and LDHA, and reduced PDK1 fluorescence intensity (P<0.05). The siPDK1 group exhibited decreased colony formation rate, reduced lactate production, increased ATP production, lowered mitochondrial membrane potential, downregulated protein levels of p-Akt, PKM2, GLUT1, PDK1, PDH, and LDHA, and reduced PDK1 and p-Akt fluorescence intensity (P<0.05). Compared with the siPDK1 group, the siPDK1+Buzhong Yiqitang group showed decreased colony formation rate, reduced lactate production, downregulated protein levels of PKM2, GLUT1, and PDK1, and reduced PDK1 fluorescence intensity (P<0.05). The siPDK1+cisplatin group exhibited decreased colony formation rate, reduced lactate production, increased ATP production, lowered mitochondrial membrane potential, downregulated protein levels of PKM2, GLUT1, PDK1, and PDH, and reduced PDK1 and p-Akt fluorescence intensity (P<0.05). The siPDK1+cisplatin+Buzhong Yiqitang group demonstrated decreased colony formation rate, reduced lactate production, increased ATP production, lowered mitochondrial membrane potential, downregulated protein levels of p-Akt, PKM2, GLUT1, PDK1, PDH, and LDHA, and reduced PDK1 and p-Akt fluorescence intensity (P<0.05). Compared with the siPDK1+Buzhong Yiqitang group, the siPDK1+cisplatin group showed decreased colony formation rate, downregulated protein levels of p-Akt and PDH, and reduced PDK1 and p-Akt fluorescence intensity (P<0.05). The siPDK1+cisplatin+Buzhong Yiqitang group exhibited decreased colony formation rate, reduced lactate production, increased ATP production, lowered mitochondrial membrane potential, downregulated protein levels of p-Akt, GLUT1, PDH, and LDHA, and reduced PDK1 and p-Akt fluorescence intensity (P<0.05). Compared with the siPDK1+cisplatin group, the siPDK1+cisplatin+Buzhong Yiqitang group showed decreased colony formation rate, increased ATP production, and downregulated protein levels of p-Akt, PKM2, and LDHA (P<0.05). ConclusionBuzhong Yiqitang combined with cisplatin can suppress lung adenocarcinoma cell proliferation by modulating glycolysis through the PDK1/Akt signaling pathway.
3.Research progress on passive strategies for drowning prevention technology
ZHU Yinchao ; WANG Sijia ; GUO Lihua
Journal of Preventive Medicine 2026;38(2):145-148
Abstract
Drowning is a global public health issue characterized by sudden occurrence, insidious presentation, and poor health prognosis, which poses higher requirements for the time sensitivity, judgment accuracy, and response reliability of drowning prevention and control technologies. Among drowning prevention and control strategies, passive strategies can achieve injury prevention and control purposes through safely designed products, making them more effective than active strategies. This paper reviewed literature, books, and patent webpages related to drowning prevention and control technologies from January 2015 to August 2025. Based on the basic characteristics of drowning, this paper summarized innovative technologies for passive strategies including physical drowning hazard environments, drowning person identification, and rescue, analyzed and compared their technical principles, applicable scenarios, advantages and disadvantages, so as to provide the evidence for promoting interdisciplinary research and practical application of drowning prevention and control technologies.
4.Epidemiological characteristics and influencing factors of lung cancer in Quanshan District of Xuzhou City
Ningning SHENG ; Mi WANG ; Yiyu WANG ; Sijia WANG
Journal of Public Health and Preventive Medicine 2025;36(1):148-151
Objective To explore the epidemiological characteristics of lung cancer in Quanshan District of Xuzhou cityand analyze the influencing factors, so as to provide theoretical guidance for the prevention and control of lung cancer in Quanshan District of Xuzhou City. Methods A total of 302 patients with lung cancer diagnosed in the Affiliated Hospital of Xuzhou Medical University were selected as case group from January 2019 to December 2023, and 300 healthy persons were selected as control group, a self-designed questionnaire was used to investigate the general and clinical information of the patients, and Logistic regression was used to analyze the risk factors.Results There were a statistically difference in two groups for the smoking index (χ2=40.058,P<0.001),Chemical occupational environment(χ2=28.153 , P<0.001), weekly exercise mode(χ2=11.021,P=0.004), emphysema score(χ2=142.812,P<0.001). In addition, the CA125 in the case group was (87.11 ± 13.09) U/ml, while the control group was (16.32 ± 5.61) U/ml, with a statistically difference (t=34.581, P<0.001). The logistic regression results showed that smoking index≥20 cigarettes per day (OR=3.448, P=0.021), chemical occupational environment (OR=4.091, P<0.001), emphysema score (OR=1.302, P<0.001) or severe (OR=1.461, P<0.001), and CA125 detection value ≥ 75U/ml (OR>1.6, P<0.001) were independent risk factors for lung cancer, while moderate weekly exercise (OR=0.821, P<0.001) was a protective factor for lung cancer. Conclusion Smoking, high CA125 index, chemical occupational environment, and long-term emphysema are risk factors for the occurrence of lung malignant tumors in Quanshan District of Xuzhou City, screening regularly of CA125 in people who have smoking, emphysema, and being chemical occupational environment should be strengthened, and appropriate health education in proper exerciseshould be provided to prevent and reduce the incidence of lung malignant tumors.
5.Prediction models for the mortality risk in traumatic hemorrhage based on machine learning
Yiquan WANG ; Sijia TIAN ; Shengmei NIU ; Zhipei HUANG ; Fei QIN ; Jinjun ZHANG
Chinese Journal of Emergency Medicine 2025;34(11):1574-1578
Objective:To evaluate the predictive performance of machine learning methods for predicting the risk of death in traumatic hemorrhage, and address the low prediction accuracy of traditional trauma scores, provide a reference for developing a more robust prediction method for severe trauma patients.Methods:Clinical data of severe trauma patients from the National Trauma Medical Center between April 1, 2023, and March 31, 2024 were collected. ElasticNet, Recursive Feature Elimination, and Mutual Information-based feature selection methods were used to screen variables and compared with traditional hypothesis testing methods. Built the prediction models for mortality risk in traumatic hemorrhage using Logistic Regression, ElasticNet, and Support Vector Machine (SVM) and compared the predictive performance.Results:The study included 5,601 trauma patients, the results of the variable screening and importance ranking were consistent with three feature selection methods. The classification accuracy and AUC values for the three models were as follows: Overall accuracy was 83.2%, survival accuracy was 84.0%, death accuracy was 76.3%, and an AUC was 0.86 in logistic regression; Overall accuracy was 78.9%, survival accuracy was 78.5%, death accuracy was 81.7%, and an AUC was 0.88 in ElasticNet; Overall accuracy was 84.7%, survival accuracy was 86.1%, death accuracy was 72.4%, and an AUC was 0.86 in SVM. The prediction performance of three models is quite little.Conclusion:Machine learning methods can effectively improve the prediction of death risk for traumatic hemorrhage,and has wide applications.
6.Prognostic model of ferroptosis-related genes in gastric cancer and experimental validation
Zhao Zhang ; Hongjun Tian ; Keshuo Ding ; Yong Zhu ; Feng Lin ; Sijia Yang ; Wenbin Wang
Acta Universitatis Medicinalis Anhui 2025;60(12):2215-2226
Objective:
To identify ferroptosis-related genes associated with gastric cancer prognosis and investigate their potential molecular functions.
Methods:
Gene expression profiles and clinical information of gastric cancer tissues and adjacent normal tissues were obtained from TCGA database. Differential expression analysis of ferroptosis-related genes was performed using the "DESeq2" package in R software. Key genes were identified and a prognostic model for gastric cancer was constructed through Cox regression analysis based on the LASSO algorithm. Patients were stratified into high-risk and low-risk groups according to the median risk score. The accuracy of the model was evaluated using Kaplan-Meier survival analysis and ROC curve analysis. Immune cell infiltration in gastric cancer patients was assessed with the "CIBERSORT" package. The mRNA expression of differentially expressed genes(DEGs) with prognostic significance was examined in both gastric cancer and adjacent normal tissue samples. In vitro experiments were conducted to validate the impact of hydroxycarboxylic acid receptor 1(HCAR1) on the malignant biological behavior of gastric cancer.
Results:
Based on ferroptosis-related genes from the TCGA database, a novel prognostic model was constructed. It demonstrated robust predictive power for survival in both training and validation cohorts. RT-qPCR analysis of 8 pairs of gastric cancer and normal tissues revealed that the expression patterns of 6 prognostic DEGs in cancer tissues were consistent with those predicted by the model. In vitro experiments confirmed that downregulation of the key gene HCAR1 could inhibit the proliferation, invasion, and metastasis of gastric cancer cells.
Conclusion
The ferroptosis-related gene based prognostic model exhibits robust predictive capability, allowing for accurate determination of prognosis and survival in individuals with gastric cancer.
7.Danzhi Jiangtang Capsule improves renal vascular endothelial function in rats with diabetic nephropathy by downregulating the Notch1/NICD/MAML1 signaling pathway
Sijia ZHU ; Jingcheng MA ; Yujiao ZHENG ; Chuanyun WU ; Jiangen ZHAO ; Lingxiu LI ; Li WANG ; Xuemei ZHOU
Journal of Southern Medical University 2025;45(10):2250-2257
Objective To investigate the therapeutic mechanism of Danzhi Jiangtang Capsule(DZJTC)for repairing renal vascular endothelial injury in rats with diabetic nephropathy(DN).Methods Fifty male SD rat models of DN,established by left nephrectomy,high-sugar and high-fat diet and streptozotocin injection,were randomized into DN model group,low-,medium-,and high-dose DZJTC treatment groups,and DAPT(a γ-secretase inhibitor)treatment group,with 10 rats with normal feeding as the control group.DZJTC was administered by daily gavage at 0.315,0.63,or 1.26 g/kg,and DAPT(20 mg/kg,dissolved in 50%CMC-Na solution)was given by gavage every other day for 4 weeks;normal saline was given in the control and model groups.After treatment,the levels of creatinine(CRE),blood urea nitrogen(BUN),and microalbuminuria(mALB)were detected with ELISA,and renal pathologies were observed by transmission electron microscopy.Renal expressions of vascular endothelial growth factor(VEGF)and endothelin-1(ET-1)were measured by immunohistochemistry,and the protein expressions of CD31 and Notch signaling pathway components were detected using Western blotting.Results The rat models of DN showed significantly increased CRE,BUN,and mALB levels,obvious renal pathologies under electron microscopy,increased renal VEGF,ET-1 and CD31 expressions,and upregulated Notch1,NICD,and MAML1 protein levels.Treatment with DZJTC at the 3 doses and DAPT significantly reduced CRE,BUN,and mALB levels,improved renal pathology,decreased VEGF,ET-1 and CD31 expressions,and lowered Notch1,NICD and MAML1 levels,and the effects were the most pronounced with high-dose DZJTC.Conclusion DZJTC ameliorates hyperproliferation and dysfunction of renal vascular endothelium in DN rats possibly by regulating renal VEGF and ET-1 levels via inhibiting NICD-and MAML1-mediated Notch signaling pathway.
8.Analysis of global clinical trial status for botulinum toxin drugs
Jiancai WU ; Tiange ZHOU ; Mengmeng WANG ; Sijia LIU
Chinese Journal of Plastic Surgery 2025;41(10):1016-1022
Objective:To analyze the current status of global clinical trial for botulinum toxin (BTX) drugs, and to provide a reference for BTX drug research priorities and trends.Methods:All registered BTX drug-related clinical trials from the inception of the platforms until December 2024 were retrieved from the International Clinical Trials Registry Platform (ICTRP) and the Center for Drug Evaluation (CDE) Clinical Trial Registration and Information Disclosure Platform of the National Medical Products Administration of China (referred to as the CDE Platform). The data were statistically analyzed using Excel 2021. The analysis was conducted from aspects such as registration volume and annual trend, distribution of conducting countries, drug type, study type and recruitment situation, and indications.Results:A total of 2 053 clinical trials related to BTX were included. The total number of registered trials showed an increasing trend year by year. The country with the largest number of clinical trials was the United States, with 571 trials, while China ranked third with 190 trials. Among the drug formulations, the injection form accounted for the highest proportion (99.02%, 2 033/2 053). A few new formulations included topical ointments, nasal sprays, and eye drops. In terms of drug serotypes and sources, the wild-type BTX-A projects accounted for a relatively high proportion (97.86%, 2 009/2 053), and also included a few wild-type BTX-B, wild-type BTX-E, recombinant BTX-AB, and recombinant BTX-A projects. In terms of research types, 90.4% (1 856/2 053) were intervention studies, 87.5% (1 796/2 053) of the clinical trials did not restrict gender, 90.7% (1 862/2 053) of the clinical trials recruited subjects covering adults, and 9.3% (191/2 053) of the clinical trials only recruited minors. The research indications covered various disciplines, such as skin beauty, neurology, urology, orthopedics, and ophthalmology. In recent years, the types of diseases registered for clinical trials had expanded significantly on the basis of the originally approved indications.Conclusion:Innovative directions in BTX drug research, including BTX drugs of different serotypes, recombinant BTX based on recombinant gene technology, BTX formulations for non-injectable delivery, and innovative areas of clinical application, are driving its continued clinical research.
9.Molecular Identification of Cremastra appendiculata and Other Original Medicinal Materials of Cremastrae Pseudobulbus and Confusing Products Based on ITS Sequences in DNA Barcodes
Jinling ZHANG ; Qiuxiao XIAO ; Qian WANG ; Sijia ZHOU ; Yali LONG ; Yong HUANG ; Lin ZHENG ; Zipeng GONG ; Yang JIN ; Yueting LI
Chinese Journal of Information on Traditional Chinese Medicine 2025;32(6):142-146
Objective To distinguish Cremastra appendiculata(D.Don)Makino,Pleione yunnanensis Rolfe and Pleione bulbocodioides,and its easily confusing products Oreorchis patens and Iphigenia indica Kunth using the ITS sequence in DNA barcodes;To explore the genetic diversity of Cremastra appendiculata germplasm resources.Methods Three different original Cremastra appendiculata,Pleione yunnanensis Rolfe and Pleione bulbocodioides,and their easily confusing products Cremastrae Pseudobulbus of Oreorchis patens and Iphigenia indica Kunth were selected as the research objects,and the genomic DNA of the above samples were extracted by the modified CTAB method,and then the ITS sequences were amplified,sequenced and spliced by PCR technology.The Kimura 2-Parameter(K2P)model was used to calculate the genetic distance,and the phylogenetic tree was constructed with the help of neighbour joining method(NJ)for genetic relationship analysis.Results Except for the Iphigenia indica Kunth species that were not found during the BLAST search,the BLAST comparison results of the other samples were higher than 95%.At the same time,the results of phylogenetic tree showed that Cremastra appendiculata,Pleione yunnanensis Rolfe and Pleione bulbocodioides were clustered into one branch,respectively,and the easily confusing products were also respectively clustered into one branch.Conclusion The ITS sequence in DNA barcodes can be used to accurately distinguish Cremastra appendiculata,Pleione yunnanensis Rolfe and Pleione bulbocodioides,and its easily confusing products Oreorchis patens and Iphigenia indica Kunth.
10.Changes in the intestinal microbiota structure of patients with colorectal adenoma
Meng SIJIA ; Li JIQIU ; Wang DAN ; Liu CHEN ; Li CHUNYAN ; Zhao JING ; Wang YU ; Du MEIZHI ; Wang YUAN ; Lu WENLI ; Zhu YUN ; Zhang KEMING
Chinese Journal of Clinical Oncology 2025;52(4):177-182
Objective:To investigate gut microbiota differences between individuals with and without colorectal adenoma(CRA)and to identify gut microbes associated with CRA.Methods:This cross-sectional study analyzed the gut microbiota of 100 patients with CRA and 68 individuals without CRA(aged 40-75 years)who underwent colonoscopies between March 2021 and March 2022 at Tianjin Nankai Hospital.Fecal samples were sequenced for the V3-V4 region of the bacterial 16S rRNA gene using the Illumina NovaSeq platform.Results:Compared to the non-CRA group,the CRA group exhibited reduced relative abundances of identified and unidentified Lachnospiraceae,with increased Faecalibacterium and Streptococcus.In the non-CRA group,the relative abundances of Coprococcus,unidentified Clostridiaceae,and Clostridium were higher.LEfSe analysis revealed significant enrichment of Gammaproteobacteria,Proteobacteria,Enterobacteriales,and Faecalibacterium in the CRA group,while the non-CRA group was enriched for Moraxellaceae,Acinetobacter,and Anaerostipes.Conclusions:These findings suggest a discernible disparity in the gut microbiota structure between CRA patients and individuals without adenoma.The enrichment of potential pathogenic taxa,such as Faecalibacterium and Streptococcus,in the CRA group suggests a possible association with adenoma development.


Result Analysis
Print
Save
E-mail